Explore how advances in accuracy, throughput and cost are making long-read sequencing more accessible at scale.
In a striking example of nature's ingenuity, a collaborative research team has revealed that a bioluminescent fish glows not ...
Earlier this year, PacBio announced a collaboration with global rare disease genomics program iHope (part of the Genetic ...
PACB's strong Q4 results, expanding sequencing tech portfolio and rising system adoption highlight growth momentum despite ...
StockStory.org on MSN
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna shares plummet, what you need to know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones ...
Zacks Investment Research on MSN
PacBio wins Basecamp Research deal for Trillion Gene Atlas initiative
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that Basecamp Research has ...
Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
"As biopharmaceutical pipelines expand targeted therapies beyond the traditional oncology space and into different areas of medicine, the demand for quality germline data has never been greater,” said ...
Whole Genome Sequencing (WGS) test now available through Foundation Medicine’s FlexOMx Lab™ to support biomarker discovery and drug development across cardiometabolic, immunologic and neurologic ...
Element Biosciences is going toe-to-toe with gene-sequencing giant Illumina, unveiling a device that can read DNA for half the price of the industry leader’s technology. On Thursday, Element ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results